Technology Development Board enters into an agreement with Panacea Biotech
To provide financial assistance of Rs 28.99 crores for the development and commercialisation of dengue tetravalent vaccine.
Panacea Biotec has signed an agreement with Technology Development Board (TDB), Govt of India for providing the financial assistance of Rs 28.99 crores for the development and commercialisation of dengue tetravalent vaccine (Live Attenuated, Recombinant, Lyophilized).”
TDB approves support for indigenous company for ramping up production of COVID-19 diagnostic kits
Real-time PCR based molecular diagnostic kit that screens and detects COVID 19 from samples of flu-like symptoms.
Technology Development Board under DST invites technology proposals for fighting COVID 19
Proposal applications from Indian companies and enterprises to address protection and home-based respiratory intervention for COVID-19 patients
National Technology Day to be celebrated focusing on rebooting the economy through S&T
The conference will bring together Scientists, Technocrats, Government officials, Diplomats, WHO officials and dignitaries from national and international Industry, Research Institutions and Academic Institutions
National Technology Day celebrations highlight surge in entrepreneurship spirit for cost effective tech
he National Technology Day celebrations highlighted an increase in entrepreneurship spirit to develop cost effective indigenous solutions.
The day is a significant milestone in the history of India’s technological innovations as India successfully tested nuclear bombs in Pokhran on May 11, 1998 and is commemorated every year by honouring the architects of such innovations. Awards are given to several innovators and entrepreneurs on this day every year.
